Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis

NCT06058299 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

309

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary TB
Pulmonary Tuberculosis
Drug Sensitive Tuberculosis

Interventions

DRUG: TBAJ-876
DRUG: Pretomanid
DRUG: Linezolid
DRUG: Bedaquiline
DRUG: HRZE
DRUG: HR

Sponsor

Global Alliance for TB Drug Development